Korify Capital

1. Executive Summary (Confidence: High)

Korify Capital is a strategic financier in the global longevity ecosystem, managing the $100 million "Korify Capital Fund ONE". The firm invests in Series A–C rounds, specifically targeting companies that address the biological drivers of aging and the low response rates of traditional mental health treatments. Korify’s investment thesis is centered on "Maintaining health and preventing illness," utilizing AI and genomics to accelerate drug discovery. With "anchor" investments in Cambrian Biopharma and Alto Neuroscience, Korify has demonstrated a track record of identifying future market leaders, including companies that have achieved successful public listings.